HARVARD BIOSCIENCE INC
HBIOUS売上高
$87M
百万USD
営業利益
$-49M
百万USD
純利益
$-57M
百万USD
ROE
-412.8%
最新FY
EPS
$-1.28
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $27M | $-1M | - |
| FY2021 | Q2 | $29M | $-0M | - |
| FY2021 | Q3 | $30M | $-0M | - |
| FY2021 | FY | $119M | $-0M | - |
| FY2022 | Q1 | $29M | $-7M | - |
| FY2022 | Q2 | $29M | $2M | $0.06 |
| FY2022 | Q3 | $27M | $-3M | - |
| FY2022 | FY | $113M | $-10M | - |
| FY2023 | Q1 | $30M | $1M | $0.01 |
| FY2023 | Q2 | $29M | $-1M | $-0.02 |
| FY2023 | Q3 | $25M | $-1M | $-0.03 |
| FY2023 | FY | $112M | $-3M | $-0.08 |
| FY2024 | Q1 | $25M | $-5M | $-0.11 |
| FY2024 | Q2 | $23M | $-3M | $-0.07 |
| FY2024 | Q3 | $22M | $-5M | $-0.11 |
| FY2024 | FY | $94M | $-12M | $-0.28 |
| FY2025 | Q1 | $22M | $-50M | $-1.14 |
| FY2025 | Q2 | $20M | $-2M | $-0.05 |
| FY2025 | Q3 | $21M | $-1M | $-0.03 |
| FY2025 | FY | $87M | $-57M | $-1.28 |
| FY2026 | Q1 | $21M | $-3M | $-0.77 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | $116M | $102M | $119M | $113M | $112M | $94M | $87M |
| 営業利益 | $-3M | $-0M | $1M | $0M | $0M | $2M | $-7M | $2M | $-6M | $-49M |
| 純利益 | $-4M | $-1M | $-3M | $-5M | $-8M | $-0M | $-10M | $-3M | $-12M | $-57M |
| 総資産 | $108M | $109M | $169M | $165M | $156M | $162M | $145M | $137M | $127M | $80M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $72M | $81M | $83M | $82M | $77M | $83M | $72M | $73M | $63M | $14M |
| 営業CF | $5M | $1M | $3M | $8M | $9M | $1M | $1M | $14M | $1M | $7M |
| EPS | $-0.13 | $-0.02 | $-0.08 | $-0.12 | - | - | - | $-0.08 | $-0.28 | $-1.28 |
| BPS | $2.09 | $2.27 | $2.20 | $2.13 | $1.93 | $2.02 | $1.71 | $1.68 | $1.44 | $0.31 |
| ROE | -6.0% | -1.1% | -3.5% | -5.7% | -10.2% | -0.3% | -13.2% | -4.7% | -19.6% | -412.8% |